Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-19
2005-04-19
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S352000, C514S340000, C514S300000, C514S335000, C544S124000, C546S312000, C546S271400, C546S269700, C546S122000, C546S261000
Reexamination Certificate
active
06881736
ABSTRACT:
Compounds of the formula (I) are disclosed which are vitronectin receptor antagonists and are useful in the treatment of osteoporosis:whereinR1is Het or ArR2isor a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 20020147334 (2002-10-01), Miller et al.
patent: WO 9915508 (1999-04-01), None
patent: WO 9945927 (1999-09-01), None
Takeno, et al., “Preparation of substituted 3-phenylpropionic . . . ,”Chem Abst. 126: Abst. 117964, (1997).
Takeno, et al., “Preparation of (oxazolyl) . . . ,”Chem Abst. 126:Abst. 89361, (1997).
Miller, et al., “Preparation of pyridinylethoxyphenybutanoates . . . ”Chem Abst. 131:Abst. 124194, (1999).
Manley Peter J.
Miller William H.
Uzinskas Irene N.
Hsu Grace C.
Kinzig Charles M.
McCarthy Mary E.
Morris Patricia L.
SmithKline Beecham Corporation
LandOfFree
Vitronectin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitronectin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitronectin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3380575